Search research articles
Contact Us
Filters
Showing results (31-40 of 103) with videos related to
Page
of 11
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
September 25, 2025
LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis
Juliette Blondel, Léo Froelicher-Bournaud, Stanislas Faguer, et al.
Future Science OA
|
December 30, 2016
Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood
Ying Qu, Gaelle Noe, Autumn R Breaud, et al.
The Oncologist
|
July 4, 2012
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis
Pascaline Boudou-Rouquette, Stanislas Ropert, Olivier Mir, et al.
Pharmacological Research
|
August 25, 2018
A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients
Benoit Blanchet, Edith Carton, Mohammad Alyamani, et al.
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement: A monocentric and retrospective French study
Paul Legendre, Benoit Blanchet, Raphael Porcher, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study
Clémence Marin, Nihel Khoudour, Aurélien Millet, et al.
Investigational New Drugs
|
November 1, 2011
Sorafenib exposure decreases over time in patients with hepatocellular carcinoma
Jennifer Arrondeau, Olivier Mir, Pascaline Boudou-Rouquette, et al.
Plos One
|
February 23, 2011
Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib
Romain Coriat, Hervé Gouya, Olivier Mir, et al.
Bioanalysis
|
June 23, 2022
Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods
Camille Tron, Florian Lemaitre, Pauline Bros, et al.
Plos One
|
December 5, 2015
Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation
Lauren Bourke, James McCormick, Valerie Taylor, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 103) with videos related to
Sort By:
Page
of 11
Journal of Pharmaceutical and Biomedical Analysis
|
September 25, 2025
LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis
Juliette Blondel, Léo Froelicher-Bournaud, Stanislas Faguer, et al.
Future Science OA
|
December 30, 2016
Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood
Ying Qu, Gaelle Noe, Autumn R Breaud, et al.
The Oncologist
|
July 4, 2012
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis
Pascaline Boudou-Rouquette, Stanislas Ropert, Olivier Mir, et al.
Pharmacological Research
|
August 25, 2018
A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients
Benoit Blanchet, Edith Carton, Mohammad Alyamani, et al.
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement: A monocentric and retrospective French study
Paul Legendre, Benoit Blanchet, Raphael Porcher, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study
Clémence Marin, Nihel Khoudour, Aurélien Millet, et al.
Investigational New Drugs
|
November 1, 2011
Sorafenib exposure decreases over time in patients with hepatocellular carcinoma
Jennifer Arrondeau, Olivier Mir, Pascaline Boudou-Rouquette, et al.
Plos One
|
February 23, 2011
Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib
Romain Coriat, Hervé Gouya, Olivier Mir, et al.
Bioanalysis
|
June 23, 2022
Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods
Camille Tron, Florian Lemaitre, Pauline Bros, et al.
Plos One
|
December 5, 2015
Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation
Lauren Bourke, James McCormick, Valerie Taylor, et al.
Page
of 11